ArticleFrontiers in microbiology2026
Clinical emergence of a novel sequence type (ST3672) NDM-1-producing
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study characterized a newly identified ST3672-type Methods: The VP1434 isolate was analyzed as follows: (1) Antimicrobial susceptibility was tested against 29 antibiotics, and plasmid conjugation experiments verified drug resistance in recipient strains post-transfer. (2) Whole-genome sequencing was used to characterize its genomic features, including plasmid sequences and inter-plasmid relationships. (3) Evolutionary tracing of VP1434 and the plasmid pVP1434-NDM was performed by constructing phylogenetic trees. (4) Virulence factors (VFs) were identified via the Virulence Factor Database, and pathogenicity was assessed through mouse infection. Results: The strain demonstrated a concerning MDR profile, exhibiting resistance to all tested Conclusion: This first report of
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.